On November 16, 2025, marking the third anniversary of Newland Pharmaceutical’s listing on the ChiNext Board of the Shenzhen Stock Exchange, the company grandly held a listing anniversary symposium themed “Three Years of Joint Progress with Gratitude, Uniting Consensus to Embark on a New Journey”. Company leaders, strategic consultants, management team members and employee representatives gathered

Gather Momentum in Mountain City, Lead with Strength | Newland Pharmaceutical Makes a Strong Debut at the 93rd API China

On October 29, Newland Pharmaceutical Co., Ltd. attended the SupplySide Global (SSG) Exhibition in the United States (hereinafter referred to as "Newland Pharma"). As one of the most influential exhibitions for the nutrition and health industry in North America, SSG brings together high-quality global brands, distributors and industry elites, serving as a core platform for identifying ma

Collaborate for Innovation, Strive for Common Development | Newland Pharma Signs Co-Development and License Agreement with Nanjing Zhihe Pharma for Long-Acting GLP-1 Peptide Innovative Drugs

The world’s premier annual pharmaceutical event — CPHI Worldwide — will take place in Frankfurt, Germany, from October 28 to 30, 2025. As the benchmark exhibition for global pharmaceutical ingredients and manufacturing industries, CPHI Worldwide is renowned as **the vane of the pharmaceutical industry** and **the Olympics of the global pharmaceutical sector** for its outstanding scale, professiona